Evidence map›Paper›PMID 32414804›Full record

ArticleAnnals of the rheumatic diseases2021

COVID-19 pneumonia in a large cohort of patients treated with biological and targeted synthetic antirheumatic drugs.

Edoardo Conticini, Elena Bargagli, Marco Bardelli, Giuseppe Domenico Rana, Caterina Baldi, Paolo Cameli, Stefano Gentileschi, David Bennett, Paolo Falsetti, Nicola Lanzarone and 5 more

Abstract readLetterComment
PubMed Publisher
In one paragraph

Article in Annals of the rheumatic diseases, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 31 papers.

0numbers the graph read from it
0cells of the map it votes in
31citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

31 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Review
  7. Review
  8. Article
  9. Article
  10. Article
  11. COVID-19 and Disease-Modifying Anti-rheumatic Drugs.Current rheumatology reports · 2021
    Review
  12. Article
  13. Impact of SARS-CoV-2 outbreak on heart and lung transplant: A patient-perspective survey.Transplant infectious disease : an official journal of the Transplantation Society · 2021
    Article
  14. Observational
  15. Review
  16. COVID-19 in Immunocompromised Hosts: What We Know So Far.Clinical infectious diseases : an official publication of the Infectious Diseases Society of America · 2021
    Review
  17. Risk Factors for Mortality after COVID-19 in Patients with Preexisting Interstitial Lung Disease.American journal of respiratory and critical care medicine · 2021
    Observational
  18. Review
  19. Article
  20. Observational
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

15 authors.

Edoardo ConticiniDepartment of Medicine, Surgery and Neurosciences, Rheumatology Unit, University of Siena, Siena, Italy conticini.edoardo@gmail.com.ORCID 0000-0002-3974-6606
Elena BargagliDepartment of Medicine, Surgery and Neurosciences, Pneumology Unit, University of Siena, Siena, Italy.
Marco BardelliDepartment of Medicine, Surgery and Neurosciences, Rheumatology Unit, University of Siena, Siena, Italy.
Giuseppe Domenico RanaDepartment of Medicine, Surgery and Neurosciences, Pneumology Unit, University of Siena, Siena, Italy.
Caterina BaldiDepartment of Medicine, Surgery and Neurosciences, Rheumatology Unit, University of Siena, Siena, Italy.
Paolo CameliDepartment of Medicine, Surgery and Neurosciences, Pneumology Unit, University of Siena, Siena, Italy.
Stefano GentileschiDepartment of Medicine, Surgery and Neurosciences, Rheumatology Unit, University of Siena, Siena, Italy.
David BennettDepartment of Medicine, Surgery and Neurosciences, Pneumology Unit, University of Siena, Siena, Italy.
Paolo FalsettiDepartment of Medicine, Surgery and Neurosciences, Rheumatology Unit, University of Siena, Siena, Italy.
Nicola LanzaroneDepartment of Medicine, Surgery and Neurosciences, Pneumology Unit, University of Siena, Siena, Italy.
Francesca BellisaiDepartment of Medicine, Surgery and Neurosciences, Rheumatology Unit, University of Siena, Siena, Italy.
Cristiana BarrecaDepartment of Medicine, Surgery and Neurosciences, Rheumatology Unit, University of Siena, Siena, Italy.
Roberto D'AlessandroDepartment of Medicine, Surgery and Neurosciences, Rheumatology Unit, University of Siena, Siena, Italy.
Luca CantariniDepartment of Medicine, Surgery and Neurosciences, Rheumatology Unit, University of Siena, Siena, Italy.
Bruno FredianiDepartment of Medicine, Surgery and Neurosciences, Rheumatology Unit, University of Siena, Siena, Italy.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

Antirheumatic AgentsCOVID-19Rheumatic DiseasesSynthetic DrugsHumansSARS-CoV-2Antirheumatic AgentsSynthetic Drugsantirheumatic agentsautoimmune diseasessarcoidosis

Identifiers

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.